Bacitracin
Polypeptide antibiotic — topical first-aid and selected systemic historical uses.
What it's for
Polypeptide antibiotic — topical first-aid and selected systemic historical uses.
What it's for
Bacitracin is a mixture of related cyclic polypeptide antibiotics produced by Bacillus species. It inhibits bacterial cell-wall synthesis and is commonly used in topical first-aid ointments for minor cuts.
What it does for the body
It inhibits bacterial cell-wall synthesis and is commonly used in topical first-aid ointments for minor cuts. Systemic use is limited because of toxicity concerns. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
Bacitracin interferes with bactoprenol recycling needed to transport peptidoglycan precursors, blocking cell-wall assembly in susceptible gram-positive organisms. Think skincare, not a prescription disease drug: the goal is how skin looks, more like softening a crease in fabric than curing an illness.
Research context
Bottom line for readers: Bacitracin has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Skin research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Bacitracin — FDA.gov search
- ClinicalTrials.gov search: Bacitracin — U.S. clinical trials registry
- Drugs@FDA search: Bacitracin — FDA drug database (if approved)
- PubMed search: Bacitracin — NCBI PubMed
- PubMed Central search: Bacitracin — NCBI PMC